Open access
75
Views
15
CrossRef citations to date
0
Altmetric
Clinical Trial Report
Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
Linong Ji1 Department of Endocrinology, Peking University People’s Hospital, Beijing, People’s Republic of China
, Kyung Wan Min2 Department of Endocrinology, Eulji Hospital, Seoul, Republic of Korea
, Juliana Oliveira3 Eli Lilly and Company, Indianapolis, IN, USA
, Thomas Lew4 Eli Lilly and Company, Taipei, Songshan District, TaiwanCorrespondence[email protected]
& Ran Duan3 Eli Lilly and Company, Indianapolis, IN, USA
Pages 243-249
|
Published online: 09 Aug 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.